A retrospective analysis of the therapeutic effects of 0.01% atropine on axial length growth in children in a real-life clinical setting
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A retrospective analysis of the therapeutic effects of 0.01% atropine on axial length growth in children in a real-life clinical setting
Authors
Keywords
-
Journal
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-18
DOI
10.1007/s00417-021-05254-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Age effect on treatment responses to 0.05%, 0.025%, and 0.01% atropine: Low-concentration Atropine for Myopia Progression (LAMP) Study
- (2021) Fen Fen Li et al. OPHTHALMOLOGY
- Biological Mechanisms of Atropine Control of Myopia
- (2020) Aradhana Upadhyay et al. Eye & Contact Lens-Science and Clinical Practice
- Myopia management in the Netherlands
- (2020) Caroline CW Klaver et al. OPHTHALMIC AND PHYSIOLOGICAL OPTICS
- Effect of Defocus Incorporated Multiple Segments Spectacle Lens Wear on Visual Function in Myopic Chinese Children
- (2020) Carly Siu Yin Lam et al. Translational Vision Science & Technology
- Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children
- (2020) Shifei Wei et al. JAMA Ophthalmology
- Efficacy in myopia control
- (2020) Noel A. Brennan et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Efficacy of atropine 0.01% for the treatment of childhood myopia in European patients
- (2019) Matteo Sacchi et al. ACTA OPHTHALMOLOGICA
- Which low‐dose atropine for myopia control?
- (2019) Safal Khanal et al. Clinical and Experimental Optometry
- Studies on retinal mechanisms possibly related to myopia inhibition by atropine in the chicken
- (2019) Ute Mathis et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study
- (2019) Jason C. Yam et al. OPHTHALMOLOGY
- Low-Concentration Atropine for Myopia Progression (LAMP) Study
- (2018) Jason C. Yam et al. OPHTHALMOLOGY
- Violet Light Exposure Can Be a Preventive Strategy Against Myopia Progression
- (2017) Hidemasa Torii et al. EBioMedicine
- Effectiveness study of atropine for progressive myopia in Europeans
- (2016) J R Polling et al. EYE
- Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2
- (2016) Audrey Chia et al. OPHTHALMOLOGY
- Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050
- (2016) Brien A. Holden et al. OPHTHALMOLOGY
- Prevalence of refractive error in Europe: the European Eye Epidemiology (E3) Consortium
- (2015) Katie M. Williams et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Increasing Prevalence of Myopia in Europe and the Impact of Education
- (2015) Katie M. Williams et al. OPHTHALMOLOGY
- Epidemiology and Disease Burden of Pathologic Myopia and Myopic Choroidal Neovascularization: An Evidence-Based Systematic Review
- (2013) Tien Y. Wong et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Atropine for the Treatment of Childhood Myopia: Changes after Stopping Atropine 0.01%, 0.1% and 0.5%
- (2013) Audrey Chia et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- An updated view on the role of dopamine in myopia
- (2013) Marita Feldkaemper et al. EXPERIMENTAL EYE RESEARCH
- Effects of muscarinic agents on chick choroids in intact eyes and eyecups: evidence for a muscarinic mechanism in choroidal thinning
- (2013) Debora L Nickla et al. OPHTHALMIC AND PHYSIOLOGICAL OPTICS
- Maximum Atropine Dose Without Clinical Signs or Symptoms
- (2013) Jeffrey Cooper et al. OPTOMETRY AND VISION SCIENCE
- The complex interactions of retinal, optical and environmental factors in myopia aetiology
- (2012) D.I. Flitcroft PROGRESS IN RETINAL AND EYE RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started